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Abstract 22 
Here we report studies of the antigenic relationships of West Nile virus (WNV) and Usutu virus 23 
(USUV), two zoonotic flaviviruses from Italy, together with a Japanese encephalitis virus (JEV) strain 24 
and compared them with their genetic relationships using the immunodominant viral E protein.  25 
Thirty-nine isolates and reference strains were inactivated and used to immunize rabbits to produce 26 
hyper immune sera.  Serum samples were tested by neutralization against all isolates and results 27 
visualized by generating antigenic map.  Strains of WNV, USUV, and JEV grouped in separate clusters 28 
on the antigenic map.  JEV was closer antigenically to the USUV (mean of 3.5 Antigenic Unit, AU, 29 
equivalent to a 2-fold change in antibody titer) than to the WNV strains (mean of 6 AU).  A linear 30 
regression model predicted on average one unit of antigenic change, equivalent to a 2-fold change 31 
in antibody titer, for every 22 amino acid substitutions in the E protein ectodomain. Overall, 32 
antigenic map was demonstrated to be robust and consistent with phylogeny of the E protein. 33 
Indeed, the map provided a reliable means of visualizing and quantifying the relationship between 34 
these flaviviruses. Further antigenic analysis employing several strains of representative 35 
serocomplex are currently underway. This will provide a more in deep analysis of antigenic 36 
relationship between flaviviruses. 37 
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INTRODUCTION 49 
Zoonotic mosquito-transmitted flaviviruses (genus Flavivirus, family Flaviviridae) constitutes one of 50 
the main challenges for human and animal health. Dengue viruses (DENV) cause around 21.000 51 
human deaths annually, and it is estimated that at least 120 countries have endemic DENV 52 
transmission (Thomas & Endy, 2011); In affected areas, Zika virus (ZIKAV) was recently shown to be 53 
responsible for microcephaly and other severe brain defects following infections of pregnant 54 
women (Chibueze et al., 2017). West Nile virus (WNV) has become more prominent as a zoonotic 55 
agent, particularly in Europe, where infections in humans, horses and birds have been reported. 56 
Humans can develop disease which may range from mild febrile illness (West Nile fever) to 57 
encephalitis with fatal outcome (Kramer et al., 2007). Usutu virus (USUV) is a close relative of WNV 58 
but was considered for decades as a flavivirus with low zoonotic potential. The first large outbreak 59 
of USUV occurred in 2001, in Austria, with a significant die-off of Eurasian blackbirds (Turdus merula) 60 
and great grey owls (Strix nebulosa) (Weissenböck et al., 2002).  Recent data from various European 61 
countries indicate that there also might be a much higher number of clinical neuro-invasive USUV 62 
infections in humans than had been assumed to date (Grottola et al., 2017; Cadar et al., 2017). Both 63 
viruses circulate worldwide in multiple genetic lineages (L) (Cadar et al., 2017; Engel et al., 2016; 64 
Bakonyi et al., 2017). According to recent surveillance, WNV and USUV are the most widespread 65 
mosquito-borne flaviviruses in Italy, with co-circulation in the same geographical areas (Mancini et 66 
al., 2017; Victoriano-Llopis et al., 2015; Grottola et al., 2017).  67 
Viruses in the genus Flavivirus are placed into complexes with shared antigenic cross-reactivity. 68 
WNV and USUV belong to the Japanese encephalitis virus (JEV) serocomplex along with viruses 69 
including JEV, Murray Valley encephalitis virus and St. Louis encephalitis virus. Other serocomplexes 70 
include yellow fever virus, DENV and tick-borne encephalitis virus, which contains three subtypes 71 
and louping ill virus (Porterfield, 1980). This classification has largely been supported by genomic 72 
phylogeny, but the correspondence between genetic and phenotypic expression is not clear. A 73 
previous study demonstrated complex antigenic relationships among the flaviviruses, but used sera 74 
from individuals that had been vaccinated against more than one virus, complicating interpretation 75 
(Mansfield et al., 2011). Thus, flaviviruses constitute a challenge for serological diagnosis and 76 
prediction of vaccine cross-protection. Indeed, specificity in flavivirus antibody-measurement is 77 
significantly hampered by the structural similarity of the viruses and the resulting antibody cross-78 
reactivity. The antigenic characteristics of flaviviruses are mainly determined by their envelope (E) 79 
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protein structures (Heinz, 1986). This protein is widely used in serological flavivirus diagnosis, as 80 
virtually all infected individuals generate quantifiable IgG antibodies against it. The E is an 81 
approximately 53 kD type I membrane glycoprotein. It has three domains (D1-D3). D1 is the N-82 
terminal structurally central domain while D2 is the dimerization domain. The D3 functions in 83 
receptor recognition and binding (reviewed in Iyer et al., 2013). Resistance of WNV to antibody-84 
mediated neutralization has been directly correlated with mutations in the epitopes of D3 (Maillard 85 
et al., 2008), and a potential role for D3 in cross-protection among flaviviruses has been suggested 86 
by results of studies in mice (Li et al., 2011). Serological cross reaction has been demonstrate to 87 
occur also between WNV and USUV (Blazquez et al., 2015). 88 
The analysis of antigenic differences within circulating viruses, with the notable exception of 89 
influenza viruses (Bedford et al., 2014) due to the pressing need for accurate vaccine strain 90 
selection, is not as timely or accurate as the genetic characterization. Despite close correspondence 91 
between genetic and antigenic variation, significant differences are observed. In influenza A virus 92 
genetic change may have a disproportionately large antigenic effect. Even one single nucleotide (nt) 93 
mutation, may have important consequences for antigenicity and receptor binding avidity (Li et al., 94 
2013; Koel et al., 2013; Lorusso et al., 2014). To visualize and quantify the antigenic relationships 95 
among influenza strains, antigenic cartography was assessed for the first time fifteen years ago for 96 
H3N2 isolated from 1968 to 2003 (Smith et al., 2004). During the last decade, this method was used 97 
to measure the antigenic distance of influenza viruses (Smith et al., 2004; de Jong et al., 2007; Russell 98 
et al., 2008; Garten et al., 2009; Lorusso et al., 2011), lyssaviruses (Horton et al., 2010), enteroviruses 99 
(Huang et al., 2009), picornaviruses (Ludi et al., 2014) and flaviviruses (Mansfield et al., 2011). In this 100 
manuscript, we show the antigenic relationships for a 33 strains of zoonotic flaviviruses (WNV and 101 
USUV) isolated in Italy in the last ten years, and compare with their genetic relationships.  102 
MATERIALS AND METHODS 103 
Viruses 104 
A total number of 25 strains including 17 WNV L1 and 8 WNV L2 isolated in Italy from different hosts 105 
and geographical areas were employed for the analysis (Tab 1). These strains are stored at the Italian 106 
Reference Laboratory for Exotic Diseases (CESME) of the Istituto Zooprofilattico Sperimentale 107 
dell’Abruzzo e Molise (IZSAM). Two WNV L1 and one WNV L2 (Eg101, NY99 and B956, respectively) 108 
reference strains were also added to the analysis. Moreover, eight USUV strains isolated from birds 109 
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in Italy were also included. Likewise, two USUV reference strains (939 and SAAR of the European 110 
and African lineages, respectively) were also added. One JEV isolate was also used for the analysis. 111 
Italian field strains used in this study represent all the isolates obtained between 2008 and 2015 112 
within the framework activities of the National surveillance plan for WNV. Isolation was performed 113 
following procedures previously described (Savini et al., 2013). 114 
Ethics 115 
All procedures on animals were accomplished respecting the European and Italian regulations on 116 
the use of animals for experimental purposes. The study was approved by the Animal Welfare 117 
Committee of IZSAM and authorized by the Italian Ministry of Health (authorization number 118 
48/2015-PR). 119 
Inactivation and production of hyperimmune sera  120 
Low cell-passages (p4, onto African green monkey kidney cells-Vero) of the field strains were used 121 
for inactivation. Inactivation was verified by propagating each virus onto Vero cells for three times 122 
followed by immunofluorescence. Inactivated viruses for immunization were prepared at 123 
approximately 106 tissue culture infective doses- TCID50/ml per 20 ml with inactivation by binary 124 
ethylenimine (BEI, 5mM; Ronchi et al., 2012) and addition of a commercial adjuvant (MontanideTM 125 
Gel, Seppic Srl, Milan-Italy) at a ratio of 1 : 1 (v/v) virus to adjuvant. Adult New Zealand white female 126 
and male rabbits (of nearly 3.0 kg of weight) were employed for production of hyperimmune serum. 127 
Rabbits were housed in wire cages (one individual per cage) under controlled environmental 128 
conditions with free access to food and water. Prior immunization, blood was collected from all 129 
animals in EDTA tubes and recovered plasma was screened to confirm the absence of WNV/USUV 130 
antibodies by cELISA (ID Screen West Nile Competition Multi-species, IDvet- Grabels, France). 131 
Rabbits were administered following sedation (Prequillan®, Fatro) and general anesthesia (Zoletil®, 132 
Virbac® + Rompun®, Bayer) with the inactivated viruses. Two rabbits per virus were immunized at 133 
day (d) 0 and d2 with inactivated virus combined with commercial adjuvant (1 ml in total) by 134 
intramuscular (IM) and intraperitoneal (IP) routes. At d4, in addition to the IM administration, 135 
inactivated virus and adjuvant (1 ml in total) were also given by a subcutaneous route. At d6, 136 
inactivated virus and adjuvant (3 ml in total) were administered by IM with four different injections 137 
of 0.75 ml each in the legs and shoulders. At d8, the same protocol of d6 was used. At d21, 138 
serological screening by serum-neutralization (SN) with the homologous strain was adopted to 139 
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confirm the seroconversion of immunized animals. At the end of the vaccination period, rabbits 140 
were humanely euthanized with Tanax® (Intervet). 141 
Serological assay 142 
Sera were heat inactivated at 56 °C. Serum samples from rabbits were tested by SN (Di Gennaro et 143 
al., 2014) against all WNV, USUV and JEV isolates used for immunization of rabbits. Briefly, starting 144 
from a dilution titer of 1:5, serial 2-fold dilutions were made in microtiter plates, and 100 tissue 145 
culture infective doses (TCID) of antigen were added to each dilution. Thereafter, the mixtures were 146 
incubated at 37°C for 1 h, and 105 Vero cells were added to each well. The plates were incubated at 147 
37°C for 5 days. Starting from the third day after incubation, the plates were checked for cytopathic 148 
effect, and the antibody titer was defined as the reciprocal of the highest dilution of the serum that 149 
showed 100% neutralization. The reciprocal of the ratio between heterologous and homologous SN 150 
titers for individual serum samples was calculated to determine the fold difference between 151 
heterologous and homologous reactions. SN plates were blinded to prevent bias.   152 
Characterization of the E protein 153 
As the E protein is the principal antigen responsible for eliciting a neutralizing antibody response, 154 
field strains were also sequenced by Next Generation Sequencing (NGS, Marcacci et al., 2016) or 155 
standard RT-PCR protocols. The amino acid sequences of the E protein of the tested strains were 156 
compared. Whole genome characterization and epidemiologic analysis of circulating field strains 157 
are currently underway (Monaco et al., manuscript in preparation). 158 
Phylogeny 159 
E protein sequences were aligned with MUSCLE (v3.8.31) configured for highest accuracy (MUSCLE 160 
with default settings). The analysis was performed on the Phylogeny.fr platform 161 
(http://www.phylogeny.fr/index.cgi). The phylogenetic tree was reconstructed using the maximum 162 
likelihood method implemented in the PhyML program (v3.1/3.0 aLRT). The default substitution 163 
model was selected assuming an estimated proportion of invariant sites (of 0.055) and 4 gamma-164 
distributed rate categories to account for rate heterogeneity across sites. The gamma shape 165 
parameter was estimated directly from the data (gamma=1.649). Reliability for internal branch was 166 
assessed using the aLRT test (SH-Like). Graphical representation and edition of the phylogenetic tree 167 
were performed with TreeDyn (v198.3). 168 
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 169 
Antigenic cartography 170 
Antigenic relationships between viruses were quantified and visualized by generating antigenic 171 
maps as previously described (Mansfield et al., 2011, Smith et al., 2004). Maps were made by 172 
calculating a target distance between each virus and antiserum from the neutralization titers and 173 
positioning the virus and antiserum on a map such that the distance between them was as close as 174 
possible to the target distance (minimizing the sum-squared error between map distance and target 175 
distance). The target distance was calculated as the difference between the logarithm (log2) 176 
reciprocal neutralization titer for that particular virus and the log2 reciprocal maximum titer 177 
achieved by that serum (against any virus), so the higher the titer, the lower the target distance. 178 
Antigenic cartography, implemented using ACMACS (www.antigenic-cartography.org)* was then 179 
used to optimize the positions of the viruses and sera relative to each other on a map. Multiple 180 
maps were made in two, three and four dimensions, by 100 random-restart optimizations, ranked 181 
in order of total error and quantitatively compared to each other, for self-consistency. Three 182 
dimensions was chosen as the most appropriate to visualise the antigenic relationships based on 183 
these analyses. 184 
RESULTS 185 
Serological assay  186 
All obtained serum samples were tested against all isolates. Results of homologous (highlighted in 187 
yellow boxes) and heterologous reactions are available in Supplementary Material.  In our setting, 188 
isolates representing the WNV species, regardless of the lineage or the year of isolation, 189 
demonstrated from null cross-reactivity to strong cross-reactivity (>1:640). Similar scenario was also 190 
revealed for USUV strains. Cross-reactivity between WNV and USUV strains was variable, ranging 191 
from null cross-reactivity to very low cross-reactivity (1:10). The lack of cross-reactivity was 192 
demonstrated between WNV strains and JEV whereas cross-reactivity between JEV and USUV 193 
ranged from no cross-reactivity to moderate cross-reactivity (1:80). 194 
Antigenic relationships 195 
The strains of USUV, WNV and JEV used in this study were demonstrated to be in separate clusters 196 
on the antigenic map (Figure 1).The total antigenic variation among the representatives of USUV 197 
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(three antigenic units, AU) was similar to the variation among the WNV isolates. Strains from WNV 198 
L1 were, however, not antigenically distinguishable from L2. Although they belong to the same 199 
serogroup, JEV was closer antigenically to the USUV (mean of 3.5 AU) than the WNV strains (mean 200 
of 6 AU). The antigenic proximity of JEV with USUV concurred with the phylogeny of the E protein 201 
(Figure 2).  The apparent clustering of sera (grey cubes) together with colored dots (viruses) in the 202 
3D map confirms that they were hyperimmune sera specifically produced for the selected viruses. 203 
However, in few cases cross-reaction was revealed between WNV and USUV and between USUV 204 
and JEV. Antigenic maps were consistent, and robust to addition/removal of viruses. Thus, antigenic 205 
cartography provided, in this case, a reliable means of visualizing and quantifying the relationship 206 
between the selected flaviviruses. 207 
Analysis of the E protein 208 
An overall aa identity of the E protein ranging from 99.4 to 100 % was demonstrated within WNV L1 209 
strains, from 99.7 % to 100 % within WNV L2 strains, 93.3 % to 95.6 % between WNV L1 and L2 210 
strains, 76.2 % to 78.0 % between WNV (regardless of the lineage) and USUV strains. Italian USUV 211 
field strains were nearly identical within each other. By employing one representative isolate for 212 
each viral genotype (Figure 3), aa relatedness with JEV E protein was 76 %, 77 % and 78 % for WNV 213 
L1, L2 and USUV, respectively. However, aa identity in the D3 domain was higher (84 %) between 214 
JEV and USUV with respect to that observed between homologous domains of JEV with WNV L1 (77 215 
%) and WNV L2 (76 %). Aa identities between homologous D1 and D2 of USUV and JEV were 73 % 216 
and 77 %, respectively.  217 
Predicting antigenic distance from amino acid sequence homology 218 
Antigenic distances measured from the antigenic map were compared with differences from an E-219 
protein amino acid similarity matrix. Each virus was compared with every other virus, giving an 220 
estimate of the correlation between antigenic and amino acid distances. Pairwise comparison of all 221 
antigenic distances with amino acid distances showed a statistically significant correlation (r = 0.91  222 
(Figure 4). In addition, a linear regression model predicts on average, one unit of antigenic change, 223 
equivalent to a 2-fold change in antibody titer, for every 22 amino acid substitutions in the E-protein 224 
ectodomain.  225 
 226 
 227 
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DISCUSSION 228 
In this study, we investigated the antigenic relationship between a number of field WNV and USUV 229 
strains which originated from biological samples collected in the last ten years during the activities 230 
of a serological, entomological and virological surveillance program for West Nile neuroinvasive 231 
disease implemented at the national level by the Italian Ministry of Health in order to control WNV 232 
circulation. While isolates used for cartography were representative of both WNV L1 and L2, which 233 
are the unique WNV lineages circulating in Italy and with distinct genomic signatures, USUV strains 234 
were all nearly identical to each other as they belonged to the main European lineage. Reference 235 
WNV and USUV strains and one JEV isolate were also included in the analysis. Whereas reference 236 
WNV strains including Eg101, NY99 and B956 belong to L1 and L2, respectively, USUV strain 1776 237 
isolated in the Republic of South Africa in 1959 is representative of the Africa 2 lineage (Cadar et al., 238 
2017).  239 
The antigenic relationships were depicted in a 3D map. This map was created by interpreting serum-240 
neutralization results. The SN method was previously tested and compared to the official plaque 241 
reduction neutralization test on human and equine serum samples by our group at IZSAM (Di 242 
Gennaro et al., 2014). The map was demonstrated to be robust and consistent with phylogeny of 243 
the E protein. Indeed, the map provided a reliable means of visualizing and quantifying the 244 
relationship between these flaviviruses. JEV was demonstrated to be antigenically closer to USUV 245 
than WNV as indicated also by phylogeny of the E protein. The highest % of aa sequence homology 246 
between JEV and USUV strains was demonstrated in the D3 domain of the E protein. As this domain 247 
has been indicated to be involved in cross-protection among flaviviruses, it is tempting to speculate 248 
that the proximity of these viruses in the antigenic map is related to the observed homology in this 249 
domain. Intriguingly, although cross reaction between JEV and WNV was not revealed in our 250 
experimental settings, previous studies demonstrated cross reaction between JEV and WNV in vitro, 251 
albeit with sera from individuals vaccinated against multiple agents (Mansfield et al., 2011) and in 252 
vivo with a prominent role of D3 as inducer of protective antibody response in mice challenged with 253 
a virulent WNV strain (Li et al., 2011). Nevertheless, antigenic cartography, which was previous 254 
applied to other pathogens, allowed high resolution quantitative analyses and visualizations of 255 
antigenic relationships between the tested field viruses. The viruses clearly grouped in three main 256 
clusters and strains of WNV L1 were not antigenically distinguishable from WNV L2 strains. One 257 
could reasonably point out that in a few cases, no cross-reactivity was evidenced between some 258 
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WNV strains. However, because antisera were tested against multiple antigens, and antigens tested 259 
against multiple antisera, many measurements were used to determine the position of the antigen 260 
and antiserum points in an antigenic map, thus increasing the accuracy of point placement beyond 261 
that of individual SN measurements. One advantage of antigenic cartography is that it is minimally 262 
dependent on individual variations in serological response compared with other interpretations of 263 
antigenic data. Indeed, assays of the same strain and antiserum can occasionally produce different 264 
values, as it is the case of this study, even in the same laboratory.  Accordingly, although cross 265 
reactions between WNV and USUV and between USUV and JEV were observed in a few cases, they 266 
did not cluster together in the map.  267 
This study clearly has some limitations. First, SN data were obtained by using hyper-immune sera 268 
raised against whole inactivated viruses, and not purified E proteins; these sera may contain, 269 
therefore, neutralizing antibodies for other viral proteins. However, the E protein is considered the 270 
major antigen of flaviviruses inducing neutralizing Ab in infected individuals and the antigenic 271 
clustering showed in this study mimics the phylogeny of the E protein. Second, neither serum 272 
samples and isolates of current WNV vaccines available for horses nor representative of other WNV 273 
lineages or other flaviviruses were used in the study. However, although the limited number of viral 274 
species, as far as we know this is the first large antigenic map assessed for flaviviruses belonging to 275 
the same serocomplex. 276 
 Results of the comparison between antigenic and amino acid sequences distances between viruses 277 
demonstrated that although there is considerable antigenic variation among viruses that are 278 
genetically similar, over 90% of the antigenic variation is predictable from the E protein amino acid 279 
sequence. Despite the clustering of the pairwise distances into three groups (caused by the three 280 
main antigenic subcomplexes) the estimate of the average number of amino acid substitutions 281 
causing a two-fold change in antibody titer is in line with previous studies on RNA viruses with single 282 
dominant surface glycoproteins, at 22 amino acids (Horton et al 2010). The individual 283 
disproportionate effect of some amino acid substitutions at important epitopes or receptor binding 284 
sites was not captured here, yet these analyses demonstrate the opportunity of using this approach 285 
combined with reverse genetics to investigate those antigenically important sites. Overall, aa 286 
mutations observed between WNV L1 and L2 strains do not change the antigenicity of the E protein 287 
thus confirming the effectiveness of current WNV vaccines for horses.  288 
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Genetic characterization of circulating viruses is one of the key activities that most laboratories, 289 
even low-throughput, have in place. This scenario is further accentuated by the availability of next 290 
generation sequencing techniques (NGS). Indeed, the development of innovative molecular 291 
technologies and of bioinformatics has greatly increased the production and release of sequence 292 
data and our knowledge of the evolution, transmission and pathogenicity of viruses. However, the 293 
analysis of antigenic differences within circulating viruses is not as timely as the genetic counterpart. 294 
In this perspective, we strongly believe that antigenic cartography needs to be coupled to NGS and 295 
genome characterization of circulating viruses. In this way, analysis of antigenic properties in a larger 296 
context (antigenic map) rather than one-by-one assay may help to predict the hazard related to the 297 
introduction of an “antigenically unknown” pathogen. Further antigenic analysis employing several 298 
strains of representative serocomplex are currently underway. This will provide a more in deep 299 
analysis of antigenic relationship between flaviviruses.  300 
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Figure Legend 432 
Figure 1. 3D antigenic map of representative historical and contemporary WNV and USUV strains. 433 
Red dots, USUV; Green dots, WNV L1; Light blue dots, WNV L2; Blue dot, JEV. 434 
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Figure 2. Phylogeny of the E protein of the flaviviruses used in the study. The phylogenetic tree 435 
was reconstructed using the maximum likelihood method implemented in the PhyML program 436 
(v3.1/3.0 aLRT). Boostrap values >70 are showed. Bar indicates the estimated numbers of aa 437 
substitutions per site. The analysis was performed on the Phylogeny.fr platform 438 
(http://www.phylogeny.fr/index.cgi). 439 
Figure 3. Alignment of the E proteins of one selected sequence per viral species.  Red, D1 domain; 440 
Blue, D2 domain; Green, D3 domain. Aa shared by USUV and JEV are highlighted in yellow.  441 
Figure 4. Plot of pairwise antigenic and genetic distances between viruses. Antigenic distances are 442 
measured from the antigenic map, in antigenic units. Genetic distances between viruses are 443 
represented as the number of amino acid substitutions in the E protein ectodomain. The line 444 
represents a linear regression model (r2 = 0.91), which predicts, on average, an antigenic distance 445 
change of one antigenic unit, equivalent to a 2-fold change in neutralization titer, per 22 amino 446 
acid substitutions. 447 
Supplementary material 448 
SN results which include homologous (yellow boxes) and heterologous reactions 449 
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 457 
 458 
Table 1. Relevant data regarding the isolates used for the present study 459 
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strain 
number 
Viral species Isolation 
material 
Host Municipality Province Year of isolation 
15076 WNV L1 Organs pool Magpie Ferrara Ferrara 2008 
15217 WNV L1 Organs pool Magpie Jolanda di Savoia Ferrara 2008 
15242 WNV L1 Plasma Donkey Tresigallo Ferrara 2008 
15802 WNV L1 Organs pool Pigeon Voghera Pavia 2008 
15803 WNV L1 Organs pool Magpie Voghera Pavia 2008 
15325 WNV L1 Plasma Horse Trecenta Rovigo 2008 
15250 WNV L1 Brain Horse Ferrara Ferrara 2008 
12010 WNV L1 Organs pool Magpie Luzzara Reggio Emilia 2009 
19883 USUV Hearth Crow Chioggia Venezia 2009 
12543 USUV Organs pool Blackbird Urbino Pesaro-
Urbino 
2010 
12628 USUV Organs pool Blackbird Treia Macerata 2010 
12962/4 USUV Hearth Blackbird Senigallia Ancona 2010 
12962/7 USUV Kidney Blackbird Senigallia Ancona 2010 
12963/2 USUV Spleen Blackbird Senigallia Ancona 2010 
12963/4 USUV Kidney Blackbird Osimo Ancona 2010 
20224/1 WNV L1 Plasma Chicken Santa Giusta Oristano 2011 
20224/8 WNV L1 Plasma Chicken Santa Giusta Oristano 2011 
21412 WNV L1 Brain Owl Oristano Oristano 2011 
23237/1 WNV L1 Plasma Chicken Arborea Oristano 2011 
14444 WNV L1 Organs pool Magpie Ro Ferrara 2011 
17196 WNV L1 Organs pool Owl Bondeno Ferrara 2011 
17208 WNV L1 Organs pool Crow Gaggio Montano Bologna 2011 
21370 WNV L1 Plasma Horse Mogoro Oristano 2011 
20168 WNV L2 Brain Goshawk Usellus Oristano 2012 
20652 WNV L1 Organs pool Magpie Latisana Udine 2012 
19882 USUV Organs pool Crow Olbia Olbia-Tempio 2012 
27449 WNV L2 Brain Goshawk Muros Sassari 2013 
19685 WNV L2 Organs pool Magpie Cavezzo Modena 2015 
21926 WNV L2 Kidney Real owl Balzola Alessandria 2015 
21863 WNV L2 Organs pool Magpie San Cesario sul Panaro Modena 2015 
21864 WNV L2 Organs pool Magpie San Cesario sul Panaro Modena 2015 
22115 WNV L2 Insect Culex 
pipiens 
Ticineto Alessandria 2015 
21865 WNV L2 Organs pool Magpie Castelfranco Emilia Modena 2015 
      Acc nos  Country and 
city 
 
Eg101 WNV L1    AF260968    Egypt   1951 
NY99 WNV L1    AF202541    New York, 
USA 
  1999 
B956 WNV L2    NC001563    Uganda   1937 
USUV 939 USUV    AY453411    Austria,Wien   2001 
USUV 
SAAR 
USUV    AY453412   South Africa 1959 
JEV 
Lederle 
JEV  Lederle 
Laboratories 
        
 460 
